Stay updated on SPR1NT Clinical Trial

Sign up to get notified when there's something new on the SPR1NT Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SPR1NT Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page has removed an erratum related to the clinical trial and postmarketing safety of Onasemnogene Abeparvovec Therapy.
    Difference
    0.3%
    Check dated 2025-05-15T20:47:12.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-01T06:17:29.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of new identifiers and collaborators related to the study of Spinal Muscular Atrophy (SMA), while extensive details about the study's methodology and inclusion/exclusion criteria have been removed.
    Difference
    35%
    Check dated 2025-04-16T20:24:00.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-09T13:21:46.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-02T00:05:44.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-02-24T22:56:34.000Z thumbnail image

Stay in the know with updates to SPR1NT Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SPR1NT Clinical Trial page.